查看購物車
  • Simplified Chinese
  • English
  • Japanese
2021-2031年亞太地區基因檢測服務市場報告（範圍、細分、動態和競爭分析）
市場調查報告書
商品編碼
1819711

2021-2031年亞太地區基因檢測服務市場報告（範圍、細分、動態和競爭分析）

Asia Pacific Genetic Testing Services Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis
出版日期: | 出版商: The Insight Partners | 英文 192 Pages | 訂單完成後即時交付

價格

亞太地區基因檢測服務市場預計將大幅成長，到 2031 年將達到 25.501 億美元，高於 2023 年的 7.2838 億美元。這一成長代表著 2023 年至 2031 年的年複合成長率(CAGR) 為 17.0%。

執行摘要和市場分析

亞太地區 (APAC) 的基因檢測服務市場正在快速擴張，這得益於醫療保健投資的增加、技術進步以及人們對遺傳疾病認知的提高等諸多因素。中國、印度、日本和韓國等主要國家對基因檢測的需求顯著成長，尤其是在癌症診斷、產前篩檢和罕見遺傳疾病的鑑定等領域。個人化醫療的發展以及基因組研究的進步，進一步推動了市場的發展。此外，旨在改善醫療基礎設施和促進基因研究的政府措施預計將促進市場的持續發展。主要行業參與者的加入也促進了該地區的創新，並提高了服務的可及性。

市場區隔分析

基因檢測服務市場可以根據服務類型、疾病和服務提供者進行細分。

1. 服務類型：市場分為幾類，包括預測檢測、帶因者檢測、產前檢測、新生兒篩檢、診斷性基因檢測等。 2023年，預測性檢測領域佔據了最大的市場佔有率。

2. 疾病：市場也依疾病類型細分，包括癌症、心血管疾病、代謝疾病和其他疾病。癌症領域是2023年市場的最大貢獻者。

3. 服務提供者：市場按服務提供者類型分類，包括醫院實驗室、診斷實驗室和其他提供者。 2023年，醫院實驗室佔據了最大的市場。

市場展望

全球遺傳疾病的發生率不斷上升，令人擔憂，因為這些疾病會嚴重影響健康。遺傳疾病通常症狀罕見，且往往無法治癒。許多此類疾病非常罕見，源自於個體基因突變。根據世界衛生組織 (WHO) 2021 年的數據，每 1,000 人中約有 10 人患有單基因疾病，這意味著全球有 7,000 萬至 8,000 萬人患有此類疾病。全球基因組織已發現約 7000 種罕見疾病和病症，且新的疾病仍在持續發現中。

謝菲爾德大學的研究估計，全球約有3億人患有遺傳疾病。 MJH生命科學公司2022年的報告強調，每年約有30萬名新生兒被診斷​​出患有鐮狀細胞疾病，約佔全球人口的5%。

在亞太和中東地區，大量個體被診斷出患有遺傳疾病，部分原因是許多社區近親結婚盛行。此類婚姻導致遺傳疾病發生率上升，從而增加了對基因檢測服務的需求，進而推動了市場成長。

國家洞察

亞太地區基因檢測服務市場主要包括中國、日本、印度、澳洲、韓國等國。中國在2023年佔據了最大的市場。

近年來，中國公眾對基因檢測益處的認知顯著提高。直接面對消費者 (DTC) 的檢測方式提高了便利性和可近性，對市場成長產生了正面影響。中國科學家和權威機構強調了遺傳物質在疾病研究和治療、藥物開發以及先天性殘疾方面的潛力。

根據2020年7月發表的一項題為《聚焦中國基因治療》的研究，中國有超過5700萬人患有遺傳疾病，每年報告約400萬例新發癌症病例。全球癌症觀察站報告稱，2020年中國共有4568754例癌症病例。此外，2023年2月發表的一篇文章指出，中國約有2,000萬人患有罕見疾病。

中國從獨生子女政策轉向全面二胎政策，預計增加出生人口，進而增加新生兒基因檢測的需求。此外，中科院於2016年啟動的「精準醫療計畫」旨在到2030年對超過1億個人類基因組進行定序，預算為92億美元。 2021年7月，中國基因公司華大基因集團與軍方合作開發了產前檢測，收集了數百萬名女性的基因資料，用於對唐氏症等性狀和異常進行廣泛研究。預計這些因素將顯著推動中國基因檢測服務市場的成長。

公司簡介

亞太地區基因檢測服務市場的主要參與者包括 Eurofins Scientific SE、Exact Sciences Corp、Laboratory Corp of America Holdings、23andMe Holding Co、Ambry Genetics Corp、Quest Diagnostics Inc、Illumina Inc、F. Hoffmann-La Roche Ltd、NeoGenomics Inc、Centogene NV Genetics, Inc、VERITAS INTERCONTINENTAL 和 GeneDx, LLC 等。這些公司正在採用擴張、產品創新和併購等各種策略來增強其產品服務並提高市場佔有率。

目錄

第1章：簡介

第 2 章：執行摘要

  • 關鍵見解

第3章：研究方法

  • 二次研究
  • 初步研究
    • 假設表述：
    • 宏觀經濟因素分析：
    • 顯影基數：
    • 數據三角測量：
    • 國家級資料：

第4章：亞太地區基因檢測服務市場－主要市場動態

  • 市場促進因素
    • 遺傳疾病盛行率上升
    • 提高對個人化醫療的認知和接受度
    • 直接面對消費者（DTC）基因檢測的偏好日益成長
  • 市場限制
    • 基因檢測的社會和倫理影響
    • 基因服務的可負擔性
  • 市場機會
    • 發展中國家尚未開發的新興市場
  • 未來趨勢
    • 人工智慧基因檢測
  • 影響分析：

第5章：基因檢測服務市場－亞太地區分析

  • 2021-2031年亞太地區基因檢測服務市場收入
  • 亞太地區基因檢測服務市場預測分析

第6章：亞太地區基因檢測服務市場分析－依服務類型

  • 預測測試
  • 攜帶者檢測
  • 產前檢查
  • 新生兒篩檢
  • 診斷性基因檢測
  • 其他

第7章：亞太地區基因檢測服務市場分析－依疾病

  • 癌症
  • 心血管疾病
  • 代謝性疾病
  • 其他疾病

第8章：亞太地區基因檢測服務市場分析－服務提供者

  • 醫院實驗室
  • 診斷實驗室
  • 其他服務提供者

第9章：亞太地區基因檢測服務市場—國家分析

  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區

第 10 章：基因檢測服務市場-產業格局

  • 概述
  • 基因檢測服務市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述

第 11 章：公司簡介

  • Eurofins Scientific SE
  • Exact Sciences Corp
  • Laboratory Corp of America Holdings
  • andMe Holding Co
  • Ambry Genetics Corp
  • Quest Diagnostics Inc
  • Illumina Inc
  • F. Hoffmann-La Roche Ltd
  • NeoGenomics Inc
  • Centogene NV
  • Ancestry Genomics Inc
  • Gene By Gene Ltd
  • SIVOTEC BioInformatics LLC
  • Progenesis
  • Fulgent Genetics, Inc
  • VERITAS INTERCONTINENTAL
  • GeneDx, LLC

第 12 章：附錄

Product Code: BMIRE00030242

The Asia Pacific genetic testing services market is projected to grow significantly, reaching an estimated US$ 2,550.10 million by 2031, up from US$ 728.38 million in 2023. This growth represents a compound annual growth rate (CAGR) of 17.0% from 2023 to 2031.

Executive Summary and Market Analysis

The genetic testing services market in the Asia Pacific (APAC) region is experiencing rapid expansion, driven by several factors including increased healthcare investments, advancements in technology, and heightened awareness of genetic disorders. Key countries such as China, India, Japan, and South Korea are witnessing a notable rise in demand for genetic testing, particularly in areas such as cancer diagnosis, prenatal screening, and the identification of rare genetic diseases. The growth of personalized medicine, alongside advancements in genomic research, is further propelling the market forward. Additionally, government initiatives aimed at improving healthcare infrastructure and promoting genetic research are expected to bolster ongoing market development. The presence of major industry players is also fostering innovation and enhancing accessibility within the region.

Market Segmentation Analysis

The genetic testing services market can be segmented based on service type, disease, and service provider.

1. Service Type: The market is divided into several categories, including predictive testing, carrier testing, prenatal testing, newborn screening, diagnostic genetic testing, and others. In 2023, the predictive testing segment held the largest market share.

2. Disease: The market is also segmented by disease type, including cancer, cardiovascular diseases, metabolic diseases, and other conditions. The cancer segment was the largest contributor to the market in 2023.

3. Service Provider: The market is categorized by service provider type, which includes hospital-based laboratories, diagnostic laboratories, and other providers. Hospital-based laboratories accounted for the largest share of the market in 2023.

Market Outlook

The increasing prevalence of genetic diseases globally is a significant concern, as these conditions can severely impact health. Genetic diseases often present with uncommon symptoms and are frequently non-curable. Many of these diseases are rare and arise from mutations in individuals' genetic makeup. According to the World Health Organization (WHO) in 2021, approximately 10 out of every 1,000 individuals are affected by single-gene diseases, indicating that between 70 million and 80 million people worldwide are living with such conditions. The Global Genes organization has identified around 7,000 rare diseases and disorders, with new ones being discovered regularly.

Research from the University of Sheffield estimates that around 300 million people globally are affected by genetic diseases. A report from MJH Life Sciences in 2022 highlighted that approximately 300,000 newborns are diagnosed with sickle cell disease each year, representing about 5% of the global population.

In the Asia Pacific and Middle East regions, a significant number of individuals are diagnosed with genetic diseases, partly due to the prevalence of consanguineous marriages in many communities. Such marriages contribute to the rising incidence of genetic disorders, thereby increasing the demand for genetic testing services, which in turn drives market growth.

Country Insights

The Asia Pacific genetic testing services market includes several key countries: China, Japan, India, Australia, South Korea, and others. China held the largest market share in 2023.

In recent years, awareness of the benefits of genetic testing has significantly increased in China. The availability of direct-to-consumer (DTC) tests has improved convenience and accessibility, positively influencing market growth. Chinese scientists and authorities have emphasized the potential of genetic material in studying and treating diseases, developing pharmaceuticals, and understanding congenital disabilities.

According to a study titled "Spotlight on Gene Therapy in China," published in July 2020, over 57 million individuals in China suffer from genetic diseases, with approximately 4 million new cancer cases reported annually. The Global Cancer Observatory reported a total of 4,568,754 cancer cases in China in 2020. Furthermore, an article published in February 2023 noted that around 20 million people in China are affected by rare diseases.

The shift from a one-child policy to a universal two-child policy in China is expected to increase the number of births, thereby enhancing the demand for newborn genetic testing. Additionally, the Precision Medicine Initiative, launched by the Chinese Academy of Sciences in 2016, aims to sequence over 100 million human genomes by 2030, with a budget of US$ 9.2 billion. In July 2021, BGI Group, a Chinese gene company, developed a prenatal test in collaboration with the military, which collects genetic data from millions of women for extensive research on traits and abnormalities such as Down syndrome. These factors are anticipated to significantly drive the growth of the genetic testing services market in China.

Company Profiles

Key players in the Asia Pacific genetic testing services market include Eurofins Scientific SE, Exact Sciences Corp, Laboratory Corp of America Holdings, 23andMe Holding Co, Ambry Genetics Corp, Quest Diagnostics Inc, Illumina Inc, F. Hoffmann-La Roche Ltd, NeoGenomics Inc, Centogene NV, Ancestry Genomics Inc, Gene By Gene Ltd, SIVOTEC BioInformatics LLC, Progenesis, Fulgent Genetics, Inc, VERITAS INTERCONTINENTAL, and GeneDx, LLC, among others. These companies are employing various strategies such as expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

Table Of Contents

1. Introduction

  • 1.1 Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Secondary Research
  • 3.2 Primary Research
    • 3.2.1 Hypothesis formulation:
    • 3.2.2 Macroeconomic factor analysis:
    • 3.2.3 Developing base number:
    • 3.2.4 Data Triangulation:
    • 3.2.5 Country-level data:

4. Asia Pacific Genetic Testing Services Market - Key Market Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Rising Prevalence of Genetic Diseases
    • 4.1.2 Increasing Awareness and Acceptance of Personalized Medicines
    • 4.1.3 Growing Preference for Direct-To-Consumer (DTC) Genetic Testing
  • 4.2 Market Restraints
    • 4.2.1 Social and Ethical Implications of Genetic Testing
    • 4.2.2 Affordability of Genetic Services
  • 4.3 Market Opportunities
    • 4.3.1 Untapped Emerging Markets in Developing Countries
  • 4.4 Future Trends
    • 4.4.1 Artificial Intelligence-Powered Genetic Testing
  • 4.5 Impact Analysis:

5. Genetic Testing Services Market - Asia Pacific Analysis

  • 5.1 Asia Pacific Genetic Testing Services Market Revenue (US$ Million), 2021-2031
  • 5.2 Asia Pacific Genetic Testing Services Market Forecast Analysis

6. Asia Pacific Genetic Testing Services Market Analysis - by Service Type

  • 6.1 Predictive Testing
    • 6.1.1 Overview
    • 6.1.2 Predictive Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.2 Carrier Testing
    • 6.2.1 Overview
    • 6.2.2 Carrier Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.3 Prenatal Testing
    • 6.3.1 Overview
    • 6.3.2 Prenatal Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.4 New-born Screening
    • 6.4.1 Overview
    • 6.4.2 New-born Screening: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.5 Diagnostic Genetic Testing
    • 6.5.1 Overview
    • 6.5.2 Diagnostic Genetic Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. Asia Pacific Genetic Testing Services Market Analysis - by Disease

  • 7.1 Cancer
    • 7.1.1 Overview
    • 7.1.2 Cancer: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.2 Cardiovascular Diseases
    • 7.2.1 Overview
    • 7.2.2 Cardiovascular Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.3 Metabolic Diseases
    • 7.3.1 Overview
    • 7.3.2 Metabolic Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 7.4 Other Diseases
    • 7.4.1 Overview
    • 7.4.2 Other Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Asia Pacific Genetic Testing Services Market Analysis - by Service Providers

  • 8.1 Hospital-Based Laboratories
    • 8.1.1 Overview
    • 8.1.2 Hospital-Based Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.2 Diagnostic Laboratories
    • 8.2.1 Overview
    • 8.2.2 Diagnostic Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • 8.3 Other Service Providers
    • 8.3.1 Overview
    • 8.3.2 Other Service Providers: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Asia Pacific Genetic Testing Services Market - Country Analysis

  • 9.1 Asia Pacific
    • 9.1.1 Asia Pacific Genetic Testing Services Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.1 Asia Pacific Genetic Testing Services Market - Revenue and Forecast Analysis - by Country
      • 9.1.1.2 China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.2.1 China: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.2.2 China: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.2.3 China: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.2.4 China: Asia Pacific Genetic Testing Services Market Share - by Service Providers
      • 9.1.1.3 Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.3.1 Japan: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.3.2 Japan: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.3.3 Japan: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.3.4 Japan: Asia Pacific Genetic Testing Services Market Share - by Service Providers
      • 9.1.1.4 India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.4.1 India: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.4.2 India: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.4.3 India: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.4.4 India: Asia Pacific Genetic Testing Services Market Share - by Service Providers
      • 9.1.1.5 Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.5.1 Australia: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.5.2 Australia: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.5.3 Australia: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.5.4 Australia: Asia Pacific Genetic Testing Services Market Share - by Service Providers
      • 9.1.1.6 South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.6.1 South Korea: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.6.2 South Korea: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.6.3 South Korea: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.6.4 South Korea: Asia Pacific Genetic Testing Services Market Share - by Service Providers
      • 9.1.1.7 Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
        • 9.1.1.7.1 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Service Type
        • 9.1.1.7.2 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Disease
        • 9.1.1.7.3 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Cancer Disease
        • 9.1.1.7.4 Rest of APAC: Asia Pacific Genetic Testing Services Market Share - by Service Providers

10. Genetic Testing Services Market - Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in Genetic Testing Services Market
  • 10.3 Organic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Inorganic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Eurofins Scientific SE
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Exact Sciences Corp
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 Laboratory Corp of America Holdings
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4andMe Holding Co
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Ambry Genetics Corp
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Quest Diagnostics Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Illumina Inc
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 F. Hoffmann-La Roche Ltd
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 NeoGenomics Inc
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments
  • 11.10 Centogene NV
    • 11.10.1 Key Facts
    • 11.10.2 Business Description
    • 11.10.3 Products and Services
    • 11.10.4 Financial Overview
    • 11.10.5 SWOT Analysis
    • 11.10.6 Key Developments
  • 11.11 Ancestry Genomics Inc
    • 11.11.1 Key Facts
    • 11.11.2 Business Description
    • 11.11.3 Products and Services
    • 11.11.4 Financial Overview
    • 11.11.5 SWOT Analysis
    • 11.11.6 Key Developments
  • 11.12 Gene By Gene Ltd
    • 11.12.1 Key Facts
    • 11.12.2 Business Description
    • 11.12.3 Products and Services
    • 11.12.4 Financial Overview
    • 11.12.5 SWOT Analysis
    • 11.12.6 Key Developments
  • 11.13 SIVOTEC BioInformatics LLC
    • 11.13.1 Key Facts
    • 11.13.2 Business Description
    • 11.13.3 Products and Services
    • 11.13.4 Financial Overview
    • 11.13.5 SWOT Analysis
    • 11.13.6 Key Developments
  • 11.14 Progenesis
    • 11.14.1 Key Facts
    • 11.14.2 Business Description
    • 11.14.3 Products and Services
    • 11.14.4 Financial Overview
    • 11.14.5 SWOT Analysis
    • 11.14.6 Key Developments
  • 11.15 Fulgent Genetics, Inc
    • 11.15.1 Key Facts
    • 11.15.2 Business Description
    • 11.15.3 Products and Services
    • 11.15.4 Financial Overview
    • 11.15.5 SWOT Analysis
    • 11.15.6 Key Developments
  • 11.16 VERITAS INTERCONTINENTAL
    • 11.16.1 Business Description
    • 11.16.2 Products and Services
    • 11.16.3 Financial Overview
    • 11.16.4 SWOT Analysis
    • 11.16.5 Key Developments
  • 11.17 GeneDx, LLC
    • 11.17.1 Key Facts
    • 11.17.2 Business Description
    • 11.17.3 Products and Services
    • 11.17.4 Financial Overview
    • 11.17.5 SWOT Analysis
    • 11.17.6 Key Developments

12. Appendix

  • 12.1 About The Insight Partners
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Asia Pacific Genetic Testing Services Market Segmentation
  • Table 2. Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Table 3. Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Type
  • Table 4. Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Disease
  • Table 5. Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Service Providers
  • Table 6. Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million) - by Country
  • Table 7. China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 8. China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 9. China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 10. China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 11. Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 12. Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 13. Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 14. Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 15. India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 16. India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 17. India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 18. India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 19. Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 20. Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 21. Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 22. Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 23. South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 24. South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 25. South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 26. South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 27. Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Type
  • Table 28. Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Disease
  • Table 29. Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Cancer Disease
  • Table 30. Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021 - 2031 (US$ Million) - by Service Providers
  • Table 31. Recent Organic Growth Strategies in Genetic Testing Services Market
  • Table 32. Recent Inorganic Growth Strategies in the Genetic Testing Services Market
  • Table 33. Glossary of Terms, Genetic Testing Services Market

List Of Figures

  • Figure 1. Asia Pacific Genetic Testing Services Market Segmentation - Country
  • Figure 2. Asia Pacific Genetic Testing Services Market - Key Market Dynamics
  • Figure 3. Impact Analysis of Drivers and Restraints
  • Figure 4. Asia Pacific Genetic Testing Services Market Revenue (US$ Million), 2021-2031
  • Figure 5. Asia Pacific Genetic Testing Services Market Share (%) - by Service Type (2023 and 2031)
  • Figure 6. Predictive Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 7. Carrier Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 8. Prenatal Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 9. New-born Screening: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 10. Diagnostic Genetic Testing: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 11. Others: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 12. Asia Pacific Genetic Testing Services Market Share (%) - by Disease (2023 and 2031)
  • Figure 13. Cancer: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 14. Cardiovascular Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 15. Metabolic Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 16. Other Diseases: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 17. Asia Pacific Genetic Testing Services Market Share (%) - by Service Providers (2023 and 2031)
  • Figure 18. Hospital-Based Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 19. Diagnostic Laboratories: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 20. Other Service Providers: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021-2031 (US$ Million)
  • Figure 21. Asia Pacific Genetic Testing Services Market Breakdown, by Key Countries, 2023 and 2031 (%)
  • Figure 22. China: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 23. Japan: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 24. India: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 25. Australia: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 26. South Korea: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 27. Rest of APAC: Asia Pacific Genetic Testing Services Market - Revenue and Forecast, 2021- 2031 (US$ Million)
  • Figure 28. Growth Strategies in Genetic Testing Services Market